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Differentiation of Human 
Keratinocytes Requires the Vitamin D 
Receptor and Its Coactivators
Wendy B. Bollag1,2
1,25-Dihydroxyvitamin D3 exerts its effects by binding to the vitamin D receptor 
(VDR), which regulates transcription of target genes by recruiting various coact-
ivators. Bikle and colleagues examined the role of several coactivators in human 
epidermal keratinocytes and found that, although these coactivators differen-
tially associate with the VDR in proliferating versus differentiating keratinocytes, 
each is required for both early and late differentiation.
Journal of Investigative Dermatology (2007) 127, 748–750. doi:10.1038/sj.jid.5700692
Nuclear hormone receptors constitute 
a family of receptors for which binding 
of ligand induces their interaction with 
specific DNA sequences to modify 
transcription of the genes controlled by 
these response elements. Among a total 
of nearly 50 nuclear hormone receptors 
(Lonard and O’Malley, 2006) are those 
for ligands including estradiol, proges-
terone, testosterone, glucocorticoids, 
mineralocorticoids, thyroid hormone, 
retinoids, peroxisome proliferator-
activated receptor agonists, and, key 
to the article by Hawker et al. (2007, 
this issue), 1,25-dihydroxyvitamin D3. 
The diversity of the nuclear hormone 
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receptor family is an important point 
because many nuclear hormones can 
heterodimerize to form active com-
plexes, and several of these receptors 
in addition to the 1,25-dihydroxyvita-
min D3 receptor (VDR) are known to 
play important roles in the epidermis 
(for instance, retinoids (see, for exam-
ple, Saitou et al., 1995) and peroxi-
some proliferator-activated receptor 
agonists (see, for example, Hanley et 
al., 2000)). Indeed, VDR is known to 
heterodimerize with the retinoid X 
receptor to induce many of its tran-
scriptional changes (although expres-
sion of other genes containing DR6, 
rather than DR3, response elements 
appears to be regulated by the retinoic 
acid receptor rather than the retinoid 
X receptor (reviewed by Bikle et al., 
2004)). Presumably, the capacity to 
heterodimerize with multiple partners 
serves in part to allow the fine-tuning 
of the patterns of gene expression in 
response to nuclear hormone receptor 
ligands in various organs and tissues.
Coactivators, which total approxi-
mately 200 (Lonard and O’Malley, 
2006), appear to serve as links between 
liganded nuclear hormone recep-
tors and the transcription machinery 
to allow regulation of gene expres-
sion, although coactivators may play 
additional roles in other facets of gene 
expression (reviewed by Lonard and 
O’Malley, 2006). One group of coacti-
vators (the steroid receptor coactiva-
tors) recruits cofactors with histone 
acetyl transferase activity and thus 
appears to regulate the accessibility of 
gene promoters to the active nuclear 
receptor–coactivator–transcription 
machinery complex; other coactiva-
tors recruit components of the tran-
scription machinery (for instance, RNA 
polymerase II) to the gene promoter 
(reviewed by Eelen et al., 2006).
There are two primary coactiva-
tor complexes that interact with the 
VDR in keratinocytes (although other 
coactivators may also interact with 
VDR (reviewed by Eelen et al., 2006)). 
The first of these is the D receptor-
interacting protein (DRIP) complex, for 
which DRIP205 (D receptor-interact-
ing protein (205 kilodaltons)) serves 
to anchor the complex to the VDR. The 
other is the steroid receptor coactivator 
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(SRC) complex, including SRC2 and 
SRC3. Evidence suggests that different 
coactivators may interact with vita-
min D response elements in a tempo-
rally defined manner. Thus, it has been 
suggested that the SRC complex, with 
its histone acetyl transferase activity, 
binds first to the vitamin D response 
element-associated VDR to induce his-
tone modification and increase acces-
sibility of the gene promoter to the 
transcriptional machinery (reviewed 
by Eelen et al., 2006). Subsequently, 
the DRIP-containing complex binds 
and recruits this machinery to initiate 
transcription (reviewed by Eelen et al., 
2006). Presumably, the differential and/
or sequential use of the diverse coacti-
vators allows cells to finely adjust their 
responses to nuclear hormone receptor 
agonists such as 1,25-dihydroxyvita-
min D3.
In the epidermis, 1,25-dihydroxyvita-
min D3 and the VDR appear to play an 
important role in keratinocyte differenti-
ation. Thus, VDR knockout mice exhibit 
reduced epidermal differentiation 
marker expression in addition to alo-
pecia (Bikle et al., 2004). Furthermore, 
1,25-dihydroxyvitamin D3 and its ana-
logues have been used successfully to 
treat psoriasis, a human skin disease 
characterized by hyperproliferation, 
abnormal differentiation, and inflam-
mation of the epidermis (reviewed by 
Fogh and Kragballe, 2004). The use of 
vitamin D analogues can be complicat-
ed by their potential to promote hyper-
calcemia; however, certain vitamin D 
analogues have been identified that 
exert less effect on serum calcium lev-
els while retaining the ability to induce 
keratinocyte differentiation (reviewed 
by Eelen et al., 2006). Indeed, certain 
of these vitamin D3 analogues appear 
to recruit a different subset of coactiva-
tors than does 1,25-dihydroxyvitamin 
D3, and this differential engagement 
may contribute to the ability of these 
analogues to act as superagonists of the 
VDR while exerting minimal effects on 
cellular calcium metabolism (reviewed 
by Eelen et al., 2006).
Bikle and colleagues (Hawker et 
al., 2007, this issue) postulated that 
the DRIP complex is required for the 
expression of early suprabasal markers, 
whereas the SRC family of coactivators 
mediates later differentiation marker 
expression. This hypothesis was based 
in part on the observed changes in the 
interaction of the coactivators with the 
VDR: DRIP is expressed and co-immu-
noprecipitates with the VDR from pro-
liferating (basal) keratinocytes, whereas 
SRC members bind to the VDR in dif-
ferentiating keratinocytes (Oda et al., 
2004). In addition, overexpression of 
SRC, but not of DRIP205, stimulates 
the promoter activity of a vitamin D 
response element linked to luciferase 
in differentiating keratinocytes treated 
with 1,25-dihydroxyvitamin D3 (Oda et 
al., 2004). Finally, neoplastic keratino-
cytes show elevated levels of DRIP205 
and increased association of VDR with 
the DRIP205 complex; these cells also 
fail to differentiate in response to 1,25-
dihydroxyvitamin D3 (reviewed by Bikle 
et al., 2005). Together, these results sug-
gest the possibility that the DRIP com-
plex might be more important in basal 
keratinocytes and/or early differentia-
tion and the SRC complex in later dif-
ferentiation.
To test this idea, Hawker et al. (2007) 
used a novel approach combining two 
powerful techniques: adenovirus-medi-
ated delivery of short hairpin RNAs 
to knock down mRNA and protein 
expression of key coactivators, as well 
as the VDR; and an advanced human 
keratinocyte differentiating system to 
simulate epidermal structure. This in 
vitro system recapitulates, to a large 
extent, the phenotype of human skin, 
exhibiting stratification and patterned 
expression of differentiation markers. In 
addition, this system has the advan-
tage over knockout mouse models that 
human keratinocytes can be genetically 
manipulated to identify cause–effect 
relationships between particular genes/
proteins and the program of human 
keratinocyte differentiation in a strati-
fied epidermal-like structure.
Amazingly, adenoviral delivery of 
the short hairpin RNAs gave sustained 
knock-down, such that differences in 
differentiation marker levels resulting 
from coactivator or VDR loss could be 
observed after the 13 days of culture 
required for complete differentiation 
of the system. Indeed, significant dif-
ferences in mRNA expression of the 
various differentiation markers exam-
ined were detected with several of 
the short hairpin RNAs relative to the 
empty adenoviral construct, as sum-
marized in Table 1. Moreover, adeno-
virus-mediated overexpression of 
the VDR induced effects opposite to 
those elicited by VDR knock-down. 
Interestingly, and in contrast to the 
original hypothesis, knock-down of 
either DRIP205 or SRC2/3 inhibited 
expression of both early and late mark-
ers, suggesting that each coactivator 
complex is necessary for both early 
and late keratinocyte differentiation, 
as is the VDR. This result could be 
related to the fact that the coactivator 
Table 1. Changes observed with vitamin D receptor overexpression or 
vitamin D receptor or coactivator knock-down by adenovirus-expressed 
short hairpin RNA
K1b K10b Involucrinb Loricrinb Filaggrinb H&E K1 IHC Loricrin 
IHC
↑ VDRa ↑ NC NC ↑ ↑ NC ↑ Broader
shVDR ↓ NC NC ↓ ↓ NC ↓ ↓
shDRIP205 ↓ ↓ ↓ ↓ ↓ NC ↓ ↓
shSRC2 NC NC NC ↓ ↓ ↑ Thickness Broader, 
diffuse
↓
shSRC3 ↓ NC NC ↓ ↓ NC ↓ ↓
Abbreviations: VDR, vitamin D receptor; sh, short hairpin; DRIP205, D receptor-interacting protein 
(205 kilodaltons); SRC, steroid receptor coactivator; K1, keratin 1; K10, keratin 10; H&E, hematoxylin 
and eosin histochemistry; IHC, immunohistochemistry; NC, no (statistically significant) change. 
aNo significant changes in keratin 5 or keratin 14 expression were observed with any manipulation. 
bChanges in mRNA levels as monitored by real-time quantitative reverse-transcriptase PCR.
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complexes interact with a variety of 
nuclear hormone receptors, as noted 
above, and therefore, knock-down 
could influence differentiative respons-
es to these other nuclear hormone 
receptor ligands as well as to 1,25-
dihdroxyvitamin D3. Alternatively, 
knock-down of one component of a 
coactivator complex might not com-
pletely inactivate the complex but might 
allow substitution by another coactiva-
tor family member, with unexpected 
results. Finally, keratinocytes might be 
similar to preadipocytes (Tang et al., 
2003) in requiring transit through the 
cell cycle in order to differentiate. Low 
concentrations of 1,25-dihydroxyvita-
min D3 can induce keratinocyte prolif-
eration (reviewed by Bikle et al., 2004); 
thus, inhibiting proliferation by knock-
down of DRIP205 (which binds to the 
VDR in basal keratinocytes (Oda et al., 
2004)) might reduce the differentiative 
capacity of these cells. In any case, it 
is clear that the mechanism by which 
1,25-dihydroxyvitamin D3 regulates 
keratinocyte differentiation is more 
complex than originally anticipated, 
and this underscores the necessity of 
further research into this clinically 
important secosteroid.
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